There’s a particular kind of frustration that comes with knee pain that just won’t quit: you’ve done the physical therapy, iced the joint more times than you can count, maybe even had a cortisone shot or two, and yet the ache is still there every time you walk down a flight of stairs. If that sounds familiar, you’re far from alone, and you may not realize that a newer treatment option now exists between “keep managing the symptoms” and “schedule a knee replacement.”
That option is genicular artery embolization, or GAE, a minimally invasive procedure that’s gaining traction among orthopedic and pain specialists alike. Below, we’ll break down what causes knee osteoarthritis in the first place, how GAE actually works, what the current research shows, who tends to benefit most, and, since cost is often the deciding factor, how to navigate getting it covered by insurance.
What Is Osteoarthritis?
At its core, osteoarthritis is a breakdown of the protective cartilage that lets your bones glide smoothly against one another. Once that cushioning wears thin, bones begin to rub, triggering pain, swelling, and a stiffness that can make even simple movements feel like a chore. The knee, which absorbs enormous amounts of stress with every step, is one of the joints hit hardest.
Sadia Saeed, MD, physician and medical advisor with Welzo, points out that osteoarthritis is often misunderstood as simple mechanical wear. In her view, the condition involves the entire joint environment, cartilage, underlying bone, synovial lining, and surrounding soft tissue, and inflammation is a bigger driver of pain than most patients assume. That inflammatory component happens to be exactly what newer procedures like GAE are designed to target.
Osteoarthritis is remarkably common. Estimates suggest it affects somewhere between one-fifth and nearly a third of adults over age 45 in the knee joint specifically, and worldwide, the number of people living with the condition has climbed past 600 million, more than double what it was in 1990. Lifetime risk estimates run as high as 40% for men and 47% for women, rising further still among people carrying excess body weight.
Signs that typically point to knee osteoarthritis include:
- Pain that flares with activity, particularly stairs, kneeling, or long periods of standing
- Stiffness after waking up or sitting for a while that eases once you get moving
- Visible swelling around the joint
- A clicking, popping, or grinding feeling during movement
- A gradual loss of the knee’s full range of motion
Because osteoarthritis is progressive, symptoms rarely stay the same for long. Many patients notice the gap between “manageable” and “disruptive” closing faster than expected, which is often what pushes them to look beyond standard first-line treatments.
What Is GAE, a New Treatment for Knee Osteoarthritis?
Genicular artery embolization takes a different approach than either medication or surgery. Rather than replacing joint tissue or masking pain signals, it addresses one of the underlying drivers of osteoarthritis pain: abnormal blood vessel activity inside the knee.
During the procedure, an interventional radiologist inserts a thin catheter, usually through the wrist or the groin, and carefully navigates it to the genicular arteries that feed the knee joint. In arthritic knees, these vessels frequently multiply and become overactive, a phenomenon known as synovial hypervascularity, which fuels inflammation and appears to heighten pain signaling in the joint lining. Using tiny embolic particles, smaller than a grain of rice, the physician selectively reduces blood flow to those inflamed areas, calming the inflammation that’s been driving the pain.
Patients are typically awake but sedated; the entire procedure takes one to two hours, and most people go home the same day. Recovery is measured in days rather than months, which stands in sharp contrast to the recovery timeline associated with total knee replacement.
What sets GAE apart from other approaches:
- No joint tissue is removed, so it doesn’t close the door on knee replacement down the road
- It targets inflammation at its source instead of simply numbing pain temporarily
- Recovery time is dramatically shorter than surgical alternatives
- It gives patients who aren’t ready for, or eligible for, joint replacement a meaningful option
The underlying embolization technique isn’t new; interventional radiologists have used it for years in other contexts, including treating uterine fibroids and joint bleeding related to hemophilia. What is new is turning that same tool toward osteoarthritis specifically, and the resulting momentum has fueled a fast-growing body of clinical research.
GAE Compared to Injections and Joint Replacement
Steroid and hyaluronic acid injections offer short-term relief, often just a few months, before symptoms return and another visit is needed. Total knee replacement, on the other hand, delivers durable results for advanced disease but requires major surgery and months of rehabilitation. GAE sits between these two extremes, offering relief that tends to last longer than injections without the extensive recovery that comes with surgery.
Research on GAE’s Effectiveness for Knee Arthritis
The clinical data behind GAE has been accumulating quickly. Registry data show technical success, meaning physicians successfully reached and treated the target vessels in about 99.7% of cases. Longer-term outcomes are similarly encouraging: across a two-year follow-up window, only about 5.2% of GAE patients ultimately required a total knee replacement. In comparison, roughly 8.3% needed a repeat embolization procedure. Reported side effects tend to be minor, most commonly temporary discoloration of the skin near the catheter insertion site.
Interest from major research institutions has followed the encouraging early results. Northwestern University currently has an active study recruiting patients with mild-to-moderate knee osteoarthritis specifically to evaluate GAE, and a separate multi-year prospective registry called RAMBO is tracking long-term outcomes through the Joint & Vascular Institute. Earlier research out of Denmark, the GETKO trial, examined GAE’s role in treating pain from mild to moderate knee OA and helped establish some of the foundational evidence that later U.S. trials have built on. UCLA also completed a dedicated safety and efficacy study of the procedure in symptomatic knee osteoarthritis patients.
A few patterns show up consistently across this research:
- Many patients report noticeable pain relief within the first few weeks after the procedure
- Relief tends to hold up longer than what’s typically seen with injections
- The complication profile compares favorably to surgical options
- Researchers are still refining exactly which patient profiles respond best
It’s fair to note that the evidence, while promising, is still maturing. Much of it currently comes from prospective registries and moderate-sized trials rather than large randomized controlled studies, and data on outcomes beyond a few years are still being collected. That’s a key reason the ongoing academic trials matter, and why most specialists currently position GAE as a strong option for patients who’ve already tried and outgrown conservative treatments, rather than as an automatic first step for everyone newly diagnosed.
Could GAE Be Right for You?
Whether GAE makes sense for you usually comes down to where you are in your osteoarthritis journey and what you’ve already tried.
Anita Gupta, DO, MPP, PharmD, FASA, board-certified anesthesiologist, pharmacist and expert in health policy and pain medicine, notes that the best candidates for GAE are generally patients with moderate knee osteoarthritis who’ve already gone through conservative options like physical therapy, anti-inflammatory medication, or injections without lasting improvement, and who are hoping to postpone surgery or aren’t good surgical candidates in the first place. She cautions that patients with severe, bone-on-bone arthritis or significant joint deformity are often still better suited to surgical treatment, underscoring why a thorough workup with an interventional radiologist or pain management specialist should come before any final decision.
Before your appointment, it’s worth thinking through:
- What conservative treatments have I already tried, and for how long?
- Does my imaging show mild-to-moderate disease, or has it progressed to advanced, bone-on-bone changes?
- Am I hoping to delay surgery, whether for personal, medical, or scheduling reasons?
- Do I have a bleeding disorder or vascular condition that might complicate embolization?
- What does my care team see when they look at inflammation and blood flow in my knee?
Consider the patient in her late 50s who’s tried three rounds of steroid injections, each one working for a couple of months before the pain returns. For someone in that position who isn’t yet ready to consider a joint replacement, GAE can represent real, practical middle ground. It won’t work identically for everyone, and setting realistic expectations with a specialist beforehand goes a long way toward avoiding disappointment.
Is GAE for Knee Osteoarthritis Covered by Insurance?
Once a patient decides GAE is worth pursuing, insurance is almost always the next question, and the answer, while not simple, is trending in a favorable direction.
As of 2026, there’s no single nationwide Medicare policy dedicated specifically to GAE. Coverage instead flows through Local Coverage Determinations set by regional Medicare Administrative Contractors, meaning approval can hinge on where you happen to live. Private insurance is similarly inconsistent from one carrier to the next. Some plans already treat GAE as medically necessary once conservative treatments have failed, while others still label it an emerging or investigational procedure, which can lead to an initial denial.
The larger trend, however, is moving in patients’ favor. As more clinical evidence accumulates, insurers are increasingly willing to view GAE as a cost-effective alternative to the repeated injections and eventual surgeries many patients would otherwise need. Approval isn’t guaranteed, but it’s more attainable than it was even a couple of years ago, especially with the right documentation in hand.
To strengthen your case for coverage:
- Keep a thorough record of every conservative treatment you’ve tried, including specific dates and outcomes
- Obtain current imaging, X-ray, or MRI, that clearly demonstrates your level of joint damage
- Ask your physician for a detailed letter of medical necessity linking your history directly to the GAE recommendation
- Check whether your plan requires prior authorization, and submit that request before you schedule the procedure
- Don’t treat a denial as final. Appeals frequently succeed once additional documentation is submitted
- Ask whether your provider’s office has staff who specialize in GAE authorizations, since this procedure is still new to many claims reviewers
If coverage still falls through after an appeal, ask your clinic directly about self-pay rates or financing options. Many practices that perform GAE regularly have already built out resources for exactly this situation.
The Bottom Line on Knee Osteoarthritis Treatment
Living with knee osteoarthritis doesn’t have to mean choosing between chronic daily pain and a major surgery you’re not ready for. Genicular artery embolization has carved out a credible middle path, supported by a growing base of clinical evidence, and it’s giving many patients real, lasting relief with a recovery period measured in days.
It’s not the right fit for everyone, and securing insurance coverage still takes some effort. Neither of those realities should stop you from bringing the topic up with your doctor. Come prepared with your imaging, a clear history of what you’ve already tried, and a list of questions. That preparation is often what separates a quick insurance denial from an approved, covered treatment plan.
Also Read | Your Heart Changes During Perimenopause: Here’s What Doctors Want You to Know
